276 related articles for article (PubMed ID: 10815698)
1. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
[TBL] [Abstract][Full Text] [Related]
2. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
[TBL] [Abstract][Full Text] [Related]
4. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
5. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
6. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
Comstock GW; Gordon GB; Hsing AW
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):219-21. PubMed ID: 8318873
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Khaw KT
J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
[TBL] [Abstract][Full Text] [Related]
8. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
Helzlsouer KJ; Gordon GB; Alberg AJ; Bush TL; Comstock GW
Cancer Res; 1992 Jan; 52(1):1-4. PubMed ID: 1530765
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulfate and breast cancer risk.
Barrett-Connor E; Friedlander NJ; Khaw KT
Cancer Res; 1990 Oct; 50(20):6571-4. PubMed ID: 2145063
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer.
Gordon GB; Helzlsouer KJ; Alberg AJ; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):33-5. PubMed ID: 8420609
[TBL] [Abstract][Full Text] [Related]
11. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
Aldred S; Mecocci P
Arch Gerontol Geriatr; 2010; 51(1):e16-8. PubMed ID: 19665809
[TBL] [Abstract][Full Text] [Related]
12. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.
Contoreggi CS; Blackman MR; Andres R; Muller DC; Lakatta EG; Fleg JL; Harman SM
J Androl; 1990; 11(5):460-70. PubMed ID: 2147671
[TBL] [Abstract][Full Text] [Related]
14. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Gordon GB; Helzlsouer KJ; Comstock GW
Cancer Res; 1991 Mar; 51(5):1366-9. PubMed ID: 1825478
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.
Gordon GB; Bush TL; Helzlsouer KJ; Miller SR; Comstock GW
Cancer Res; 1990 Jul; 50(13):3859-62. PubMed ID: 2141293
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
18. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
19. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study).
Enomoto M; Adachi H; Fukami A; Furuki K; Satoh A; Otsuka M; Kumagae S; Nanjo Y; Shigetoh Y; Imaizumi T
J Am Geriatr Soc; 2008 Jun; 56(6):994-8. PubMed ID: 18422949
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Barrett-Connor E; Khaw KT; Yen SS
N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
